LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence

LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. Introduction Methamphetamine dependence is a growing public health concern. There is currently no pharmacotherapy approved for methamphetamine dependence. Lis...

Full description

Bibliographic Details
Main Authors: Ezard, N., Dunlop, A., Hall, M., Ali, R., McKetin, Rebecca, Bruno, R., Phung, N., Carr, A., White, J., Clifford, B., Liu, Z., Shanahan, M., Dolan, K., Baker, A., Lintzeris, N.
Format: Journal Article
Published: BM J Group 2018
Online Access:http://hdl.handle.net/20.500.11937/71722

Internet

http://hdl.handle.net/20.500.11937/71722

Similar Items